Cameron covers biotechnology and pharmaceutical companies with a particular focus on financing and mergers and acquisitions activity.

Cameron joined BofA Securities in July 2022. Prior to BofA Securities, Cameron spent a decade with Guggenheim Securities helping build the biotechnology and pharmaceutical business.  Prior to Guggenheim Securities, Cameron worked for Piper Jaffray & Co. (now Piper Sandler).

BA from Pomona College.